ASAP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.664300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.351200E-01
Normal-vs-Stage2
7.220100E-02
Normal-vs-Stage3
5.805400E-01
Normal-vs-Stage4
6.348200E-02
Stage1-vs-Stage2
2.492600E-01
Stage1-vs-Stage3
6.263000E-01
Stage1-vs-Stage4
1.274170E-01
Stage2-vs-Stage3
1.433370E-01
Stage2-vs-Stage4
3.137400E-01
Stage3-vs-Stage4
8.924300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.032550E-01
Normal-vs-AfricanAmerican
2.247800E-01
Normal-vs-Asian
1.209620E-01
Caucasian-vs-AfricanAmerican
8.963000E-01
Caucasian-vs-Asian
5.126000E-01
AfricanAmerican-vs-Asian
7.359800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.165560E-01
Normal-vs-Female
8.299800E-02
Male-vs-Female
7.585400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.668000E-01
Normal-vs-Age(41-60Yrs)
7.652200E-02
Normal-vs-Age(61-80Yrs)
1.090840E-01
Normal-vs-Age(81-100Yrs)
1.354650E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.784000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.613400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.983400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.067700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.752600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.232400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.322300E-02
Normal-vs-Daily Drinker
2.452800E-01
Normal-vs-Weekly Drinker
2.137200E-01
Normal-vs-Occasional Drinker
7.050000E-02
Normal-vs-Social Drinker
2.687900E-02
Non Drinker-vs-Daily Drinker
9.043000E-01
Non Drinker-vs-Weekly Drinker
7.394600E-01
Non Drinker-vs-Occasional Drinker
1.627750E-01
Non Drinker-vs-Social Drinker
8.555200E-01
Daily Drinker-vs-Weekly Drinker
7.390800E-01
Daily Drinker-vs-Occasional Drinker
3.444400E-01
Daily Drinker-vs-Social Drinker
7.904800E-01
Weekly Drinker-vs-Occasional Drinker
1.920360E-01
Weekly Drinker-vs-Social Drinker
8.601600E-01
Occasional Drinker-vs-Social Drinker
1.414590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.533620E-01
Normal-vs-Grade 2
2.281600E-02
Normal-vs-Grade 3
2.246300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.624500E-03
Grade 1-vs-Grade 3
2.977300E-04
Grade 1-vs-Grade 4
1.533620E-01
Grade 2-vs-Grade 3
3.132100E-02
Grade 2-vs-Grade 4
2.281600E-02
Grade 3-vs-Grade 4
2.246300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.751410E-01
Normal-vs-NonDiabetic
9.135800E-02
Diabetic-vs-NonDiabetic
3.166200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.385900E-02
Normal-vs-NoPancreatitis
1.201370E-01
Pancreatitis-vs-NoPancreatitis
6.985400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.158980E-01
Normal-vs-N1
8.018200E-02
N0-vs-N1
2.036000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.337800E-03
Normal-vs-TP53-NonMutant
2.472200E-01
TP53-Mutant-vs-TP53-NonMutant
3.15660000027584E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
